PECAM1 and stroke disorder: As shown in Fig. 2f, along with the time after stroke, immunofluorescence showed that enhanced Ki67 (marker of proliferation) colocalized with CD31 (marker of ECs) was most apparent on the 21st day after stroke, and 12/15-LO gene knockout blocked these effects.